Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Boehringer Ingelheim
Johnson and Johnson
Chubb
Accenture
Baxter
Fish and Richardson
Daiichi Sankyo

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BUSPAR

« Back to Dashboard

Clinical Trials for Buspar

Trial ID Title Status Sponsor Phase Summary
NCT00174226 Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar Completed Pfizer Phase 2 Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
NCT00178971 Serotonin 1A Agonists and Cognition in Schizophrenia Completed National Alliance for Research on Schizophrenia and Depression Phase 3 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antispycotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
NCT00178971 Serotonin 1A Agonists and Cognition in Schizophrenia Completed Vanderbilt University Medical Center Phase 3 Examines cognitive functioning in patients with schizophrenia or schizoaffective disorder who have been treated with antipsychotic medications. Patients will be assigned to take active medication (Buspar)or placebo along with their prescribed antispycotic medication for six weeks. Patients' memory and problem-solving ability will be tested before and after medication.
NCT00652730 Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions Completed Phoenix International Life Sciences, Inc. Phase 1 To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets
NCT00652730 Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions Completed Par Pharmaceutical, Inc. Phase 1 To compare the single-dose bioavailability of Par and Bristol-Myers Squibb Buspirone HCl Tablets
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Buspar

Condition Name

Condition Name for Buspar
Intervention Trials
Healthy 2
Sleep Disordered Breathing 1
Autism Spectrum Disorder (ASD) 1
Traumatic Brain Injury 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Buspar
Intervention Trials
Disease 3
Depressive Disorder 1
Marijuana Abuse 1
Brain Injuries 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Buspar

Trials by Country

Trials by Country for Buspar
Location Trials
United States 22
Canada 3
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Buspar
Location Trials
Maryland 2
Massachusetts 2
North Dakota 2
North Carolina 2
Texas 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Buspar

Clinical Trial Phase

Clinical Trial Phase for Buspar
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2 3
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Buspar
Clinical Trial Phase Trials
Completed 8
Recruiting 4
Withdrawn 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Buspar

Sponsor Name

Sponsor Name for Buspar
Sponsor Trials
Teva Pharmaceuticals USA 2
Par Pharmaceutical, Inc. 2
Phoenix International Life Sciences, Inc. 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Buspar
Sponsor Trials
Other 11
Industry 7
NIH 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Merck
Julphar
Federal Trade Commission
Express Scripts
Healthtrust
US Department of Justice
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.